nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
An easily applicable single condition–based mortality index for patients undergoing radical prostatectomy or radical cystectomy
|
Froehner, Michael |
|
2017 |
35 |
1 |
p. 32.e17-32.e23 3.1999967999999995E24 p. |
artikel |
2 |
A review for clinicians: Prostate cancer and the antineoplastic properties of metformin
|
Hankinson, Stephen J. |
|
2017 |
35 |
1 |
p. 21-29 9 p. |
artikel |
3 |
A review of the PD-1/PD-L1 checkpoint in bladder cancer: From mediator of immune escape to target for treatment 1 1 MPS is an investor in and consultant for Urogen. SAP is consultant and advisor for Vaccinex. The remaining authors have nothing to disclose.
|
Zhou, Tian C. |
|
2017 |
35 |
1 |
p. 14-20 7 p. |
artikel |
4 |
Central zone lesions on magnetic resonance imaging: Should we be concerned?
|
Tan, Wei Phin |
|
2017 |
35 |
1 |
p. 31.e7-31.e12 3.0999690000001E13 p. |
artikel |
5 |
Changes in expressions of ADAM9, 10, and 17 as well as α-secretase activity in renal cell carcinoma
|
Erin, Nuray |
|
2017 |
35 |
1 |
p. 36.e15-36.e22 3.59999964E23 p. |
artikel |
6 |
Clinicopathological, functional, and immediate oncologic outcome assessment in men aged≤50 years with prostate cancer after robotic prostatectomy
|
Samadi, David B. |
|
2017 |
35 |
1 |
p. 30.e17-30.e24 2.9999997E25 p. |
artikel |
7 |
Current beliefs and practice patterns among urologists regarding prostate magnetic resonance imaging and magnetic resonance–targeted biopsy
|
Muthigi, Akhil |
|
2017 |
35 |
1 |
p. 32.e1-32.e7 3.19999681E8 p. |
artikel |
8 |
Early chemotherapy discontinuation and mortality in older patients with metastatic bladder cancer: The AGEVIM multicenter cohort study
|
Laurent, Marie |
|
2017 |
35 |
1 |
p. 34.e9-34.e16 3.39999966E17 p. |
artikel |
9 |
Editorial Board
|
|
|
2017 |
35 |
1 |
p. i- 1 p. |
artikel |
10 |
Evaluation of beta-blockers and survival among hypertensive patients with renal cell carcinoma
|
Parker, William P. |
|
2017 |
35 |
1 |
p. 36.e1-36.e6 3.5999641E7 p. |
artikel |
11 |
External validation of the pathological nodal staging score in upper tract urothelial carcinoma: A population-based study
|
Xylinas, Evanguelos |
|
2017 |
35 |
1 |
p. 33.e21-33.e26 3.299967E27 p. |
artikel |
12 |
KIFC1 induces resistance to docetaxel and is associated with survival of patients with prostate cancer
|
Sekino, Yohei |
|
2017 |
35 |
1 |
p. 31.e13-31.e20 3.09999969E21 p. |
artikel |
13 |
Localized chromophobe carcinomas treated by nephron-sparing surgery have excellent oncologic outcomes
|
Bigot, Pierre |
|
2017 |
35 |
1 |
p. 35.e15-35.e19 3.4996499999999997E20 p. |
artikel |
14 |
Malignant urachal neoplasms: A population-based study and systematic review of literature
|
Mylonas, Konstantinos S. |
|
2017 |
35 |
1 |
p. 33.e11-33.e19 3.299999967E20 p. |
artikel |
15 |
Management of non–clear cell renal cell carcinoma: Current approaches
|
Tsimafeyeu, Ilya |
|
2017 |
35 |
1 |
p. 5-13 9 p. |
artikel |
16 |
Masthead
|
|
|
2017 |
35 |
1 |
p. IFC- 1 p. |
artikel |
17 |
miR-144-3p as a novel plasma diagnostic biomarker for clear cell renal cell carcinoma
|
Lou, Ning |
|
2017 |
35 |
1 |
p. 36.e7-36.e14 3.599999640000001E15 p. |
artikel |
18 |
Molecular complexity of taxane-induced cytotoxicity in prostate cancer cells
|
Mang, Josef |
|
2017 |
35 |
1 |
p. 32.e9-32.e16 3.19999968E17 p. |
artikel |
19 |
Pathologic response in patients receiving neoadjuvant chemotherapy for muscle-invasive bladder cancer: Is therapeutic effect owing to chemotherapy or TURBT?
|
Brant, Aaron |
|
2017 |
35 |
1 |
p. 34.e17-34.e25 3.399999966E26 p. |
artikel |
20 |
Prostate-specific antigen vs. magnetic resonance imaging parameters for assessing oncological outcomes after high intensity–focused ultrasound focal therapy for localized prostate cancer
|
Dickinson, Louise |
|
2017 |
35 |
1 |
p. 30.e9-30.e15 2.999997E16 p. |
artikel |
21 |
Retrospective evaluation of ultrasound-indeterminate renal multilocular cystic masses by using neutrophil-lymphocyte ratio and computed tomography
|
Wang, Hanfeng |
|
2017 |
35 |
1 |
p. 35.e7-35.e14 3.499999650000001E15 p. |
artikel |
22 |
Risk of lymph node metastases in pathological gleason score≤6 prostate adenocarcinoma: Analysis of institutional and population-based databases
|
Wenger, Hannah |
|
2017 |
35 |
1 |
p. 31.e1-31.e6 3.0999691E7 p. |
artikel |
23 |
Table of Contents
|
|
|
2017 |
35 |
1 |
p. ii-iv nvt p. |
artikel |
24 |
The difficulty in selecting patients for cytoreductive nephrectomy: An evaluation of previously described predictive models
|
Manley, Brandon J. |
|
2017 |
35 |
1 |
p. 35.e1-35.e5 3.499651E6 p. |
artikel |
25 |
The evolution of financial incentives in the U.S. health care system
|
Darves-Bornoz, Annie L. |
|
2017 |
35 |
1 |
p. 1-4 4 p. |
artikel |
26 |
Treatment of ureteral anastomotic strictures with reimplantation and survival after cystectomy and urinary diversion
|
Helfand, Alexander M. |
|
2017 |
35 |
1 |
p. 33.e1-33.e9 3.2999999671E10 p. |
artikel |
27 |
Tumor contact with prostate capsule on magnetic resonance imaging: A potential biomarker for staging and prognosis
|
Kongnyuy, Michael |
|
2017 |
35 |
1 |
p. 30.e1-30.e8 2.999999701E9 p. |
artikel |
28 |
Upstaging of nonurothelial histology in bladder cancer at the time of surgical treatment in the National Cancer Data Base
|
Cohen, Andrew J. |
|
2017 |
35 |
1 |
p. 34.e1-34.e8 3.399999661E9 p. |
artikel |